Company overview
Horizon Discovery provides cell engineering tools and services using gene editing technologies like CRISPR, base editing, and RNAi for basic research, drug discovery, and therapeutic development. Their offerings include research reagents, screening and cell line engineering services, BioProduction cell lines for biologics manufacturing, and reference standards for diagnostics. These solutions support gene function studies, target identification, pathway exploration, and precision medicine applications.
Horizon Discovery is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents partner serving United States & Americas. Core focus areas include gene editing, crispr screening, cell line engineering, rnai reagents, base editing.
Industry categories: Life Science Reagents. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Horizon Discovery include Reagent — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://horizondiscovery.com
- Categories
- Life Science Reagents
- Markets served
- United States & Americas
- Keywords
- gene editing, crispr screening, cell line engineering, rnai reagents, base editing
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What gene editing technologies does Horizon Discovery offer?
- Horizon offers CRISPR-Cas9, base editing, and RNAi technologies, including predesigned genome-wide knockout reagents, lentiviral guide RNAs, and tools for HDR knock-in and site-specific editing.
- What services are available for drug discovery and cell line engineering?
- Services include functional genomic screening with CRISPR and RNAi, single cell RNAseq-linked CRISPR screening, custom cell line engineering, and engineered models for target validation and patient population studies.
- What applications do Horizon's cell lines support?
- Horizon's cell lines enable study of functional mutations at endogenous levels, target identification and validation, identification of responsive or resistant patient populations, biologics manufacturing with CHO lines, and disease mechanism research.
Related editorial coverage
- Eli Lilly and Verve's Gene Editor: A Breakthrough in Cholesterol Management
- ASGCT 2026: Manufacturing Innovations Day 1 Roundup
- Intellia Therapeutics Achieves First-Ever Positive Phase 3 Results for In Vivo Gene Editing with Lonvoguran Ziclumeran in Hereditary Angioedema
Explore lab tools and QA/QC resources for R&D teams.
